Filter by field:

Sort by name:

Albert Wolkerstorfer

Department of Dermatology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands

a.wolkerstorfer@amsterdamumc.nl

Dermatology

Albert Wolkerstorfer practices in Amsterdam, the Netherlands. Wolkerstorfer is rated as an Elite expert by MediFind in the treatment of Vitiligo. His clinical research consists of co-authoring 135 peer reviewed articles and participating in 6 clinical trials in the past 15 years. In particular, he has co-authored 65 articles and participated in 2 clinical trials in the study of Vitiligo.

Alberto Di Martino

Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna Italy.

alberto.dimartino@ior.it

Hip Musculoskeletal disorders musculoskeletal oncology Orthopedics Spine

Alberto Di Martino, MD, Ph.D., is an Associate Professor in Orthopedics at the University of Bologna since 2019. He was an Assistant Professor in Orthopaedics at the University Campus Bio-Medico of Rome. Since 2017, he has been Adjunct Professor in Orthopaedic Surgery at the Sidney Kimmel Medical College of Thomas Jefferson University, Philadelphia (USA). He completed his MD and Ph.D. at the Università Campus Bio-Medico di Roma in Rome, with broad research interests in medical and surgical emergencies in the hip, spine, musculoskeletal oncology, orthopedics, and musculoskeletal disorders. Prof. Di Martino is the author or co-author of more than 200 publications.

His clinical and research activity is directed toward hip surgery, spine diseases and surgery, and osteoncology.

Alexander Knuth

Department of Medical Oncology and Hematology, Division of Medical Oncology, University Hospital Zurich, Zurich, Switzerland

Faculty of Medicine, University of Zurich, Zurich, Switzerland

alexander.knuth@gmail.com

Cancer Immunology Medical oncology

Dr. Alexander Knuth is a Professor of Medicine and Medical Oncology at the University of Zürich, Zürich, Switzerland, and Professor Emeritus since 2013. From 2013 to 2020, he was Chief Executive Officer and Medical Director of the National Center for Cancer Care and Research of the National Public Healthcare Provider Hamad Medical Corporation of the State of Qatar in Doha, Qatar. His research interests are cancers of the gastrointestinal tract, skin cancers, cancer immunology, and cancer immunotherapy.

His pioneering work in cancer immunology led to the discovery of multiple human cancer antigens, including MAGE, the first of the so-called cancer/testis (CT) antigens that have been a primary target of vaccine strategies to date. He also played a pivotal role in the development of peptide-based vaccines and adjuvants, established immune-monitoring techniques, and discovered tumor escape mechanisms. 

Ali Mobasheri

Research Unit of Health Science and Technology, Faculty of Medicine, University of Oulu, 90220 Oulu, Finland

State Research Institute Centre for Innovative Medicine, 08410 Vilnius, Lithuania

Department of Joint Surgery, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China

ali.mobasheri@oulu.fi

Biomarkers of osteoarthritis Biomimetic joint-on-chip platforms Cartilage biology Cellular metabolism Ion channel physiology

Dr. Ali Mobasheri is a professor of Musculoskeletal Biology in the Research Unit of Health Sciences and Technology within the Faculty of Medicine at the University of Oulu in Finland. He also holds the position of Chief Researcher and International Adviser at the State Research Institute Centre for Innovative Medicine in Vilnius, Lithuania. He is the immediate past president of the Osteoarthritis Research Society International (OARSI). He also serves on the Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis, and Musculoskeletal Diseases (ESCEO). In addition, he serves as Collaborateur Scientifique de l'Université de Liège and Senior Strategic Advisor to the World Health Organization Collaborating Center for Public Health Aspects of Musculoskeletal Health and Aging, Université de Liège, Liège, Belgium. He is a member of the International Cartilage Regeneration and Joint Preservation Society (ICRS) and serves on the Regulatory and Industry Liaison Committee of ICRS.

Ali's current research focuses on cartilage biology, the development of biomimetic joint-on-chip platforms, and the study of cellular metabolism, ion channel physiology, and biomarkers of osteoarthritis. 

He has published more than 370 scientific articles and review articles (370 papers in PubMed, 401 papers in Scopus). His current h-index on Scopus is 73. He has more than 17,500 citations. He ranks as one of the top 10 leading experts in the world on osteoarthritis and cartilage on expertscape.com. Ali already leads a multidisciplinary team of researchers in Vilnius and is building a new team of researchers at the University of Oulu. His work is currently funded by the Academy of Finland, the Lithuanian Research Council, and several funding mechanisms of the European Commission, including FP7, Horizon Europe, the COST Association, EuroNanoMed, and the Innovative Health Initiative.

Allard van der Wal

Department of Pathology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands

a.c.vanderwal@amsterdamumc.nl

Pathology Cardiovascular pathology

Allard van der Wal specializes in the pathology of the heart and blood vessels and the skin. He has both clinical and scientific experience in cardiovascular pathology. His main research lines are the pathology of acute cardiac death, atherosclerosis and thrombosis, and tumors of blood vessels. Van der Wal's research is closely linked to patient care. 

Andrea Schlegel

Department of Surgery and Transplantation, Swiss Hepato-Pancreato-Biliary (HPB) Center, University Hospital Zurich, Zurich, Switzerland

schlegel.andrea@outlook.de

Oncology Surgery Hepatobiliary surgery Transplantation

Dr. Andrea Schlegel is an academic transplant surgeon at the Cleveland Clinic, specializing in liver transplantation and hepatobiliary surgery. Her treatment philosophy is focused on a patient-centric and shared decision-making approach while incorporating the most recent innovative treatment concepts and technologies as she helps patients through their liver transplant journey.
Her research interests include both experimental and clinical research in abdominal surgery, with a focus on organ preservation to improve the safe utilization of organs. She has a lot of experience in designing clinical trials, and she works closely with her colleagues from different specialties, both at Cleveland Clinic and also within her large international network in the field.

Andreas Kremer

Department of Gastroenterology and Hepatology, University Hospital Zürich, Zürich, Switzerland

Andreas.Kremer@usz.ch

Gastroenterology Hepatology Oncology

Andreas Kremer is a clinical scientist and Professor of Hepatology at the Department of Gastroenterology and Hepatology, University Hospital Zürich. He is Head of Hepatology, Vice President of the Department, and the lead investigator for several clinical trials. He runs a lab group focusing on autoimmune and cholestatic liver disease, liver fibrosis, hepato- and cholangiocellular carcinoma, the gut-liver axis, and extrahepatic manifestations such as pruritus and fatigue.

Andrew G. Lee

Department of Ophthalmology, Blanton Eye Institute, Houston Methodist Hospital, Houston, TX, USA

aglee@houstonmethodist.org

Neurology Oncology Ophthalmology Surgery Neurosurgery

Dr. Lee received his first faculty appointment in 1994 as an instructor in the Department of Ophthalmology, Neurology, and Neurosurgery at the Baylor College of Medicine in Houston, Texas. He became an Associate Professor there in 1998 and a member of the key clinical faculty in the following year. In 2000, Dr. Lee joined the faculty at the University of Iowa in Iowa City, IA, as an Associate Professor and later a full Professor in the Department of Ophthalmology, Neurology, and Neurosurgery. Dr. Lee is a recipient of the Honor Award, Secretariat Award, and Senior Achievement Award from the American Academy of Ophthalmology. Resident training is a particular interest of Dr. Lee. He has published several papers on teaching and competency testing methods in ophthalmology residency programs. Dr. Lee joined Houston Methodist Hospital and Research Institute in 2009 and is currently Chair of the Blanton Eye Institute at Houston Methodist Hospital and Professor of Ophthalmology, Neurology, and Neurosurgery at the Weill Cornell Medical College.

Bhagavatula Moorthy

Department of Pediatrics, Division of Neonatal-Perinatal Medicine, Baylor College of Medicine, Texas Children's Hospital, Houston, TX, USA

BxMoorth@TexasChildrensHospital.org

Acute lung injury (ALI)/ARDS Bronchopulmonary dysplasia (BPD) Cytochrome P450 regulation Mechanisms of hyperoxic lung injury

Dr. Bhagavatula Moorthy, joined the Department of Pharmacology at Baylor College of Medicine as a research associate, and was a junior faculty member at Baylor in the early 1990s. He joined the section of Neonatology in the Department of Pediatrics at Baylor in 1995. Currently, he is the Director of Neonatology Research Program at Baylor. He earned tenure in 2005, and was promoted to full professor with tenure in 2011. A major goal of the research conducted in Dr. Moorthy’s laboratory is to investigate the mechanisms of regulation of cytochromes P450 (CYP) enzymes by hyperoxia, in relation to hyperoxic lung injury and inflammation. He has been working in the general area of cytochrome P450 and drug metabolism for the past 37 years. He has published extensively in the area of P450, drug metabolism, and oxidative stress. Thus far, he has published over 130 peer-reviewed research papers. 

Bote Bruinsma

Vertex Pharmaceuticals, Boston, MA, USA

botebruinsma@gmail.com

Experimental medicine Hepatology Pharmacology

Bote G. Bruinsma is from Harvard University and the Department of Surgery. His research topics are liver surgery, liver diseases, liver transplantation, hepatocellular carcinoma, biliary tract diseases, liver cirrhosis, tissue engineering, and transplantation.

Brigitte Vollmar

Institute of Experimental Surgery, University of Rostock, Rostock, Germany

brigitte.vollmar@med.uni-rostock.de

Oncology Surgery Hepatobiliary surgery

Brigitte Vollmar graduated from the Bernhard-Strigel-Gymnasium in Memmingen in 1981. She then studied chemistry at the University of Erlangen-Nuremberg in 1981–82. She then moved to the Ludwig Maximilian University of Munich and studied human medicine there from 1982 to 1988. From 1988 to 1990, she was an intern doctor at the Surgical Clinic and Polyclinic, Downtown Clinic, and received her medical license in 1990. In the same year, she did a research stay at the Department of Anesthesiology, College of Medicine at the University of Arizona. She then became a scholarship holder of the Dr. Johannes Heidenhain Foundation, and in 1991, she received her M.D. at the Institute for Surgical Research at the Ludwig Maximilians University in Munich. Her work focuses on experimental surgery, regenerative medicine, and tissue engineering. She specializes in research into organ damage and repair, particularly of the liver, pancreas, and brain. Another area of research is molecular imaging of small animals.

Daniele Botticelli

ARDEC Academy, Viale Giovanni Pascoli 67, 47923 Rimini, Italy

daniele.botticelli@gmail.com

Bone volume augmentation Dental implant Histology Oral surgery Sinus floor elevation

Dr. Daniele Botticelli is an academic researcher from the United States Army Armament Research, Development and Engineering Center. He has contributed to research on topics such as osseointegration and implants. He has an h-index of 36 and has co-authored 178 publications, receiving 5090 citations. Previous affiliations of Dr. Botticelli include the University of Gothenburg and Sao Paulo State University.

Das Undurti

UND Life Sciences, 2221 NW 5th St., Battle Ground, WA 98604, USA

undurti@hotmail.com

Cytokines Eicosanoids Essential fatty acids Free radicals Nitric oxide

Das Undurti is a physician and scientist. He is involved in translational research in cancer, diabetes mellitus, lupus, coronary heart disease, atherosclerosis, sepsis, and radiation protection. His studies led to a deeper understanding of the role of essential fatty acids (EFAs) and their metabolites, prostaglandins, leukotrienes, thromboxanes, lipoxins, resolvins, protectins, and maresins, in several diseases that have the potential to be translated into newer therapeutic strategies. He has published more than 550 manuscripts in international journals and is an editor of three journals. He has published four books, obtained five US patents, and edited two books on autism. He has promoted 16 PhD students and supervised many medical doctor (internal medicine) students.

 

Emerito Carlos Rodríguez-Merch

Department of Orthopedic Surgery, La Paz University Hospital, 28046 Madrid, Spain

Department of Osteoarticular Surgery Research, Hospital La Paz Institute for Health Research—IdiPAZ (La Paz University Hospital—Autonomous University of Madrid), 28046 Madrid, Spain

ecrmerchan@hotmail.com

Ankle Hemophilia Knee Musculoskeletal diseases Orthopedic surgery Osteoarthritis

E. Carlos Rodriguez-Merchan is a Consultant Orthopaedic Surgeon (Emeritus) at La Paz University Hospital of Madrid, Spain, and at the Osteoarticular Surgery Research, La Paz Hospital Institute for Health Research – IdiPAZ (La Paz University Hospital – Autonomous University of Madrid), Madrid, Spain. He has an extensive background in orthopaedic surgery. Consequently, he is the author of numerous peer-reviewed publications on orthopaedic surgery. He serves on the Editorial Board of several journals. He is also the editor of several books related to orthopaedic surgery.

Enrico Lopriore

Willem-Alexander Children’s Hospital, Department of Paediatrics, Division of Neonatology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands

e.lopriore@lumc.nl

Hematology Neonatology Fetal therapies

Enrico Lopriore is a professor of neonatology and fetal medicine and head of the Neonatal Intensive Care Unit at the Leiden University Medical Center (LUMC).

Erik Schadde

Department of Surgery, Rush University Medical Center, Chicago, IL, USA

erik_schadde@rush.edu

Oncology Surgery Hepatobiliary surgery Transplantation

Erik Schadde, MD, FACS, FEBS (HPB), trained in general surgery in Boston, in transplantation at the University of Wisconsin-Madison, was an attending in transplant surgery at the University of Kansas, Kansas City, and became the head of liver transplantation at Saint Louis University Medical Center in 2009. To develop his clinical and research interests in complex liver surgery involving the induction of liver regeneration, Schadde moved to the Swiss HPB center of the University of Zurich in 2010 as a consultant surgeon and rapidly became the head of the HPB fellowship program there.

Fausto Catena

Department of General Surgery, Level I Trauma Center, Bufalini Hospital, AUSL Romagna, 47521 Cesena, Italy

faustocatena@gmail.com

Colorectal surgery Emergency surgery General surgery Minimally invasive surgery Surgical education

Prof. Dr. Fausto Catena is currently the Chief of the Department of Emergency Surgery at Parma University Hospital. He graduated in Medicine and Surgery from the University of Bologna, Italy. He is also the General Secretary of the World Society of Emergency Surgery (WSES) and Director of the WSES Educational Program.

Fei Sun

Department of Otolaryngology-Head and Neck Surgery, Xijing Hospital, Fourth Military Medical University, Xi'an, China

susannajoke@163.com

Otolaryngology Surgery

Fei Sun is from the Department of Otolaryngology—Head and Neck Surgery, Xijing Hospital, Fourth Military Medical University, Xi'an, China. Her research topics are otolaryngology and surgery.

Ferran Cuenca Martínez

Department of Physiotherapy, University of Valencia, 46010 Valencia, Spain

fecuen2@gmail.com

Action observation Chronic pain Motor imagery Motor learning Pain

Dr. Ferran Cuenca-Martínez, PT, PhD, is an assistant professor in the Department of Physiotherapy, University of Valencia, Spain, teaching statistics and methodology related to health research and respiratory pathophysiology. His field of study is the management and approach to chronic musculoskeletal pain. He also has a line of research regarding the basic and clinical effects of movement representation strategies (motor imagery and action observation training) applied to the treatment of patients with persistent pain, as well as other clinical populations such as patients with respiratory disorders. He has published more than 100 papers in peer-reviewed journals.

Francjan J. van Spronsen

f.j.van.spronsen@umcg.nl

Inborn errors of metabolism Molybdenum cofactor deficiency Neonatal blood screening Phenylketonuria (PKU) Pyridoxin dependent epilepsy Tyrosinemia defects in metabolism of amino acids Metabolic diseases

Prof. Francjan van Spronsen is a pediatrician in metabolic diseases at the Beatrix Children’s Hospital, University Medical Centre of Groningen (UMCG).

He was appointed as a full professor in pediatrics with a special interest in defects in amino acid metabolism at the University of Groningen. He is also in charge of the Division of Metabolic Diseases in the Children’s Hospital of the UMCG. Currently, he treats patients with metabolic diseases from birth into late adulthood. Before that, he was trained to become an MD, after which he joined the metabolic diseases division, combining PhD research on PKU and tyrosinemia type I with clinical work. He was later trained to become a general pediatrician. He also served as a pediatrician in various children’s clinics for chronic diseases and as the supervisor of a clinical ward for general pediatrics.

His present research focus is on the causes and consequences of defects in amino acid metabolism in both basic research with in-vitro and animal studies and the relationships between metabolic control, patient disease severity, quality of dietary management, outcomes (both neurocognitive, neuropsychological, and social), and the improvement of these abnormalities, resulting in some 170 papers, of which some 100 on PKU, or Tyrosinemia type I only.

At the university level, he has served in various coordinating roles for education programs and has been chairing the Exam Committee for MDs. He is now chairing the committee to judge the applications for MDs to enter the UMCG MD/Ph.D. program.

At a national level, he chairs the Advisory Committee on Neonatal Screening concerning inherited metabolic diseases and is a member of the Dutch Committee on Neonatal Screening. At an international level, he chairs the Scientific Advisory Board of the European Society of PKU and Allied Disorders. He is also a member of various European and international advisory boards and working groups for various defects in amino acid metabolism. Along with Prof. Dr. Stefan Koelker and Prof. Dr. Henk Blom, he coordinates the MetabERN subnetwork of ‘Amino Acid and Organic Acidurias’.

He was in the lead of 19 European PKU experts who published their first papers on the first-ever European guidelines for PKU in the Lancet Diabetes & Endocrinology and Metabolism and the Orphan Journal of Rare Diseases.

Gaetano Isola

Department of General Surgery and Surgical-Medical Specialties, School of Dentistry, University of Catania, 95124 Catania, Italy.

gaetano.isola@unict.it

Dentistry Oral medicine Periodontology

Gaetano Isola is an Associate Professor of Periodontology at the School of Dentistry at the University of Catania, Italy, and qualified in Dentistry in 2009 at the University of Messina, Italy. Ph.D. in “Physiopathology of the Stomatognathic Apparatus and Dental Materials” at the University of Turin, Turin, Italy. Dr. Isola is an advisor on several research projects and a speaker at national and international conferences on periodontology and oral surgery. He is an author of over 150 national and international peer-reviewed publications. His main research interests focus on the clinical, biological, and pharmacological aspects of periodontitis and the relationship between oral health and systemic health.

Georgios Antonios Margonis

Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA

MargoniG@mskcc.org

Biliary tract diseases Cancer Hepatobiliary surgery Hepatocellular Carcinoma Liver surgery Metastasis Pancreatic diseases Tumors

Georgios Antonios Margonis is a senior scientist affiliated with the Department of Surgery at the Memorial Sloan Kettering Cancer Center (MSKCC) and the Massachusetts Institute of Technology (MIT). He obtained his MD and PhD degrees from the University of Athens and moved to the United States in 2014. Since then, he has worked at Harvard University and Johns Hopkins University, prior to working at MSKCC and MIT. His clinical and research interests include cancer, tumors, hepatocellular carcinoma, metastasis, biliary tract diseases, hepatobiliary surgery, pancreatic diseases, liver surgery, hepato-pancreato-biliary diseases, and soft tissue sarcomas. In particular, his work focuses on the use of biomarkers to guide surgical or medical treatment. More recently, he has collaborated with a group from MIT to conduct research at the crossroads of artificial intelligence and oncology. He has authored or co-authored more than 170 papers and has received several national and international awards. Notable awards include the IHPBA Kenneth Warren Award and the Johns Hopkins University Paul Ehrlich Award for outstanding research achievements.

Giuseppe Lanza

Dean of Applied Medical Sciences Techniques, University of Catania, Italy

giuseppe.lanza1@unict.it

Cerebrovascular diseases Dementia Neurosonology Non-invasive brain stimulation Sleep disorders

Giuseppe Lanza, MD, PhD, is an Associate Professor of Dean of Applied Medical Sciences Techniques at the University of Catania (Italy). After graduating with honors in Medicine, he trained at the School of Neurology and got an international PhD. As a Clinical Research Fellow, he was trained further in clinical neurophysiology at Newcastle University (UK). More recently, he has obtained a Master of Science in Clinical Research and the National Scientific Qualification as a Full Professor. He is also a consultant neurologist at the Oasi Research Institute-IRCCS in Troina (Italy), a WHO Collaborating Center, where he also coordinates a research unit. He has published many full articles and reviews in peer-reviewed journals. As a peer reviewer, he has helped many journals review a lot of manuscripts. With his expertise in clinical activity, he has published 145 papers in peer-reviewed journals (H-index Scopus 36). He has authored more than 200 scientific publications and serves as editor and reviewer for several international journals.

Giuseppe Murdaca

Department of Internal Medicine, Clinical Immunology Unit, University of Genoa and Ospedale Policlinico San Martino, 16126 Genoa, Italy

giuseppe.murdaca@unige.it

Allergies Atherosclerosis Autoimmunity Immune-mediated diseases Immunodeficiency Neuroendocrine-immunology Pharmacogenomics

Prof. Giuseppe Murdaca received his PhD in Science and Space Engineering at the University of Genova (Italy) from 2000 to 2003. He is an assistant professor at the Department of Internal Medicine of the University of Genova (Italy).

His research has included immunodeficiency, autoimmunity, neuroendocrino-immunology, and pharmacogenomics, and he has received several awards and honors based on this research and fellowship training, including a prize for young researchers in the study, assigned by the GILS, with the following motivation: "Standardization of a method to assess impairment by skinfold thickness skin", delivered on the occasion of "Day VII Italian to fight Scleroderma" (Milan, 17/3/2001). He also won the award for one of the three best oral presentations at the Ninth Congress of the Inter-SIMI Piemonte and Valle D'Aosta, Liguria (Genoa, 06.17.2004): Murdaca G., Fenoglio D., M. Setti, Brenci S., Villa R., Pontali E., A. Kunkl, Indiveri F., Puppo F. "Generation of CD4 + lines specific for Pneumocystis carinii and Candida albicans obtained from HIV + patients. Meaning of the coexpression of IFN-g and IL-4". He serves as an editorial member and expert reviewer for several reputed journals.

Giuseppe Nasso

Department of Cardiac Surgery, Anthea Hospital, GVM Care & Research, 70124 Bari, Italy

gnasso@libero.it

Atrial fibrillation Minimally invasive surgery Mitral valve surgery

Dr. Giuseppe Nasso, MD, PhD, Department of Cardiac Surgery, Anthea Hospital, Italy. He specializes in multiple coronary artery bypass grafts, heart valve treatment, and minimally invasive surgery. He is the creator of patents in the field of cardiac surgery, an authoritative associate editor of scientific journals, and a highly competent principal investigator with extensive experience in research and cardiac surgery. His research interests involve participation in research groups with national and international collaborations, specifically the "RADIAL PROJECT." This project has led to several scientific publications related to coronary artery bypass surgery and the comparison of radial artery grafts with saphenous vein grafts. Additionally, he's been involved in various clinical trials related to cardiac surgery.

Giuseppe Nigri

Oncologic Colorectal Surgical Unit and Robotic Surgery Unit, Department of Medical and Surgical Sciences and Translational Medicine, Sapienza University of Rome, 00189 Rome, Italy

giuseppe.nigri@uniroma1.it

Abdominal wall surgery Colorectal surgery Gastric surgery HPB surgery Minimally invasive surgery

Prof. Giuseppe Nigri is a full professor of Medical and Surgical Sciences and Translational Medicine at the Sapienza University of Roma. His major interests are surgical oncology and minimally invasive surgery. He is USMLE/ECFMG-certified. He trained in Italy and the USA (Clinical and Research Fellow and Resident in General Surgery) at the Massachusetts General Hospital, Harvard Medical School, Boston, MA. He is a Fellow of the American College of Surgeons, a Fellow of the Royal College of Surgeons, and a Fellow of the Society of Surgical Oncology. He has been a member of the International Relations Committee and chair of the Scholar Selection Subcommittee of the American College of Surgeons. He is also a fellow, member, and committee member of SAGES, SSAT, SSO, and the International Society of Surgery (ISS_SIC). He has authored or co-authored more than 300 international scientific publications. He is a member of numerous prestigious editorial boards.

Giustino Varrassi

Department of Research, Paolo Procacci Foundation, 00193 Roma, Italy

giuvarr@gmail.com

Anesthesiology Pain medicine

Prof. Giustino Varrassi graduated cum laude in Medicine in Roma (Italy) in 1973, where he started his academic career in the Department of Anesthesiology and Intensive Care. Four years later, he moved to the University of L’Aquila (Italy), where in 1985, he became Chairman of the Anesthesiology and Pain Medicine Department. In L’Aquila, he has created all the Academic Anesthesia and Pain Medicine programs, including the residency program. At this moment, he is President of the Paolo Procacci Foundation, an NGO based in Roma, and is involved in research and education on Pain Medicine.

At the beginning of his professional life, his research interests were mainly in Obstetric Anesthesia and Analgesia. From the beginning of the Nineties, he was mainly attracted by research on Pain Medicine, especially inflammatory pain. He has also developed an interest in the social impact of pain (SIP) at any level. On the last topic, in 2010, he created a European annual event of awareness, initially organized inside the European Parliament.

Guglielmina Pepe

Department of Experimental and Clinical Medicine (DMSC),Tuscany CRR Marfan Syndrome and Related Disorders, University of Florence, Careggi University Hospital, Florence, Italy

guglielmina.pepe@unifi.it

Determinants of inherited aortic Inherited connective tissue diseases Multivessel aneurisms

Guglielmina Pepe, MD, Ph.D., runs a hereditary connective tissue disease and syndromic and non-syndromic hereditary aneurysms/dissection service at Villa Donatello, Sesto Fiorentino, Florence, Italy. Formerly Associate Professor of Clinical Pathology at the University of Florence, Coordinator of rare vascular pathologies for the Tuscany Region, Italy, Member of VASCERN, the European group of rare vascular pathologies. She graduated with an MD from the Second School of Medicine of the University of Naples, Italy. She did postgraduate hematology training at the University of Pavia and Naples, Italy, and at the Clinical Hematology Branch, NIH, Bethesda, MD, USA, and inherited connective tissue diseases training at Rutgers Medical School, UMDNJ, NJ, USA. Her research interests are the determinants of inherited aortic and multivessel aneurysms and inherited connective tissue diseases. In particular, she is interested in the prevention, early detection, gene detection and involvement, molecular mechanisms, molecular and clinical biomarkers, and genotype-phenotype correlation of these disorders. Her research spans from basic science to clinical and molecular investigation. She has published over 140 scientific papers or book chapters.

Gundu H.R. Rao

Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN 55455, USA

gundurao9@gmail.com

hypertension Metabolic diseases Obesity type-2 diabetes Thrombosis Vascular diseases

Prof. Gundu Hirisave Rama Rao is an Indian scientist, entrepreneur, and Emeritus Professor at the Academic Health Center, University of Minnesota. He is the founder of the South Asian Society on Atherosclerosis and Thrombosis and AayuSmart LLC, an IT-supported web-based health management company. He has been actively involved in creating awareness, developing educational and preventive programs to prevent non-communicable diseases such as hypertension, obesity, metabolic diseases, type 2 diabetes, vascular diseases, and stroke.

Hananel E.G. Holzer

The Fertility Partners, Toronto, ON, Canada

Department of Obstetrics and Gynecology, McGill University Montreal, Montreal, QC, Canada

hananelholzer@gmail.com

Psychosocial aspects of infertility Fertility preservation Pre-implantation genetic testing

Dr. Hananel Holzer is the Medical Director of Third-Party Reproduction and Medical Education at The Fertility Partners Network. Till recently, he served as the Director of the R.E.I. and I.V.F. Departments and the Associate Director of the Division of Obstetrics and Gynecology at the Hadassah Medical Organization in Israel. Dr. Holzer is the former medical director of the McGill University Health Centre Reproductive Centre and the Reproductive Endocrinology and Infertility Division of McGill University in Montreal. He is also involved in developing fertility-related projects around the world, mainly in Central Europe.

Dr. Holzer holds an adjunct professor appointment in the McGill University Department of Obstetrics and Gynecology in Montreal. He is the author of over a hundred publications in the field of infertility, a member of the editorial boards of several journals, and a highly regarded invited speaker around the world. His main interests are fertility preservation for cancer patients, in-vitro maturation of oocytes, and a comprehensive team approach to infertility-related issues.

Heinz Kölbl

Chairman of the Division of Gynaecology and Gynecological Oncology,Dept. of Obstetrics and Gynaecology Medical University of Vienna, Austria

heinz.koelbl@meduniwien.ac.at

Gynaecological oncology Gynaecological surgery Urogynaecology

Heinz Kölbl, M.D., DR h.c., is a Professor of Obstetrics and Gynaecology and Chairman of the Division of Gynaecology and Gynecological Oncology, Department of Obstetrics and Gynaecology Medical University of Vienna, Austria. He passed various medical education programs in internal medicine, general surgery, nephrology, oncology, neurology, and neonatology. His medical education in obstetrics and gynecology started in 1983 at the former 2nd Department of Obstetrics and Gynecology, University (Wertheim Clinic) of Vienna. His research interests were all forms of gynaecologic surgery, urogynaecology, and gynaecologic oncology. He is an Associate Editor and Reviewer of various international journals, and his scientific work comprises over 578 papers (> 330 Medline Citations Koelbl-H or Kolbl-H - Search Results - PubMed (nih.gov)) published in standard and top journals, seven books so far, and various chapters in the German and Anglo-American literature (25 Academia.edu). He has performed many clinical and nonclinical studies in the fields of Gynaecology Oncology and Urogynecology. (H-index Scopus 52). Since 2016, Prof. Kölbl has been acting as coordinator of the Comprehensive Cancer Center at the Medical University of Vienna. In 2017, Prof. Kölbl will host the 20th Congress of the European Society of Gynaecological Oncology in Vienna. Prof. Kölbl has organized many national and international meetings in Vienna. Prof. Kölbl is the forthcoming Chairman of the Department of Gynecology at Shangdong University in China and a Member of the Editorial Board of the Royal Board of Medicine UK.

Herbert Simões

Catholic University of Brasilia, Taguatinga DF, Brazil

hgsimoes@gmail.com

Exercise physiology Physiology

Dr. Herbert Simoes is an Exercise Physiologist, primarily focused on researching the anti-aging effects of physical exercise in master athletes. He has also conducted studies related to blood glucose and blood pressure control through physical exercise in individuals with diabetes and hypertension, as well as comparisons of functional evaluation methods in athletes and non-athletes within his main research line, "Physical Activity, Exercise, and Human Performance."

He earned both a master's and a doctoral degree in Physiological Sciences from the Federal University of São Carlos, Brazil, and pursued his doctoral training at the Laboratory of Food, Nutrition, and Exercise Sciences at Florida State University. Additionally, he completed post-doctoral research at the University of Miami, Miller School of Medicine, with a focus on Clinical Research.

Dr. Simoes has held the position of Chair and is currently a Professor in the Master's and Ph.D. programs in Physical Education at the Catholic University of Brasília, Brazil. With 278 articles published in indexed journals, he is recognized as a CNPq PQ1 Research Productivity Scholar.

Beyond his academic achievements, Dr. Simoes has been an athlete since the age of 14, achieving the titles of World Master Champion in the 110m and 400m Hurdles, and he currently holds the South American Master Record. With over 30 years of experience as an athlete and coach, he has also contributed to youth and adolescent life skills development programs through sports as a Consultant/Trainer for the United Nations.

Hidekazu Suzuki

hsuzuki1201@gmail.com

Functional Gastrointestinal Disorders (FGIDs) Gastroesophageal reflux disease (GERD) Helicobacter pylori infection

Prof. Hidekazu Suzuki is a professor at the Department of Gastroenterology, Department of Internal Medicine, School of Medicine, Tokai University. He became the director of the Clinical Training Department at Tokai University Hospital in 2019. He became the director of the Keio University School of Medicine Specialist Training Center in 2017. He has devoted his research to helicobacter pylori, gastroenterology, endocrinology, and immunology.

Hiroshi Yoshida

Department of Laboratory Medicine, The Jikei University Kashiwa Hospital, Chiba 277-8567, Japan

hyoshida@jikei.ac.jp

Atherosclerosis Cardiovascular Medicine Clinical Nutrition Laboratory medicine Lipid metabolism Oxidative stress

Hiroshi Yoshida, M.D., Ph.D., FACP, FAHA, is a Professor in the Department of Laboratory Medicine at Jikei University School of Medicine and holds a joint appointment as Professor of Internal Medicine specializing in Metabolism and Nutrition at Jikei University Graduate School of Medicine. He obtained his Ph.D. degree from the National Defense Medical College. He served as a Research Fellow at the University of California San Diego, USA. He received the Encouragement Prize from the Japanese Society of Laboratory Medicine in 2004 and the Life Science Award from the Japanese Society of Laboratory Medicine in 2009. His research interests include Atherosclerosis, Cardiovascular Medicine, Clinical Nutrition, Laboratory Medicine, Lipid Metabolism, and Oxidative Stress. He has published over 100 papers indexed in PubMed.

Hiroyuki Sakurai

Department of Respiratory Surgery, Nihon University School of Medicine, Tokyo, Japan

sakurai.hiroyuki@nihon-u.ac.jp

Cognition disorders Multiple Sclerosis Neuroimaging Neuroimmunology

Dr. Hiroyuki Sakurai graduated from the Faculty of Medicine at the University of Yamanashi in Japan in 1994. He received his medical degree and doctorate from the University of Yamanashi. He completed his residency in general surgery and a clinical fellowship in thoracic surgery at the National Cancer Center Hospital, Tokyo (1998–2003). He also served as an attending surgeon (thoracic surgery) from 2009 to 2016. Since October 2016, he has been serving as a professor in the Division of Respiratory Surgery at Nihon University School of Medicine, Tokyo, Japan. 

Ibrahim Ince

Translational Medicine and Clinical Pharmacology Data Sciences, Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany

dr.ibrahimince@gmail.com

Pharmacology Pharmacometrics

Ibrahim Ince is from Translational Medicine and Clinical Pharmacology Data Sciences, Boehringer Ingelheim Pharma GmbH & Co. KG. His research topics are pharmacology and pharmacometrics.

Ipsita Roy

Department of Materials Science and Engineering, Faculty of Engineering, University of Sheffield, Sheffield S10 2TN, UK

i.roy@sheffield.ac.uk

Microbial biotechnology Natural biomaterials and their biomedical applications

Previously to joining the Department of Material Science and Engineering as a Professor of Biomaterials, Prof. Ipsita Roy was a professor at the School of Life Sciences, University of Westminster, London. She is also a visiting professor at the National Heart and Lung Institute, Faculty of Medicine, Imperial College London. She was at the University of Westminster from 2000 until August 2019, where she was the Research Director of the School of Life Sciences and led the Applied Biotechnology Research Group.

She received the prestigious Inlaks Scholarship and the Overseas Research Students Award to study for her PhD at the University of Cambridge. During her time at Cambridge, she also received the Churchill College Scholarship, the Lundgren Scholarship, the Leche Trust Scholarship, and the Cambridge University Philosophical Society Fellowship Award. Her PhD at the Department of Biochemistry was on a B12-dependent enzyme, methylmalonyl-CoA mutase. Her postdoctoral work was at the University of Minnesota, USA, at the Bioprocess Technology Institute, where she worked on fatty acid biosynthesis.

She has published over 100 papers in high-impact-factor journals, such as Biomaterials, Biomacromolecules, Journal of the Royal Society Interface, Acta Biomaterialia, and ACS Applied Materials Interfaces, and has presented her work at numerous international conferences.

Irami Araújo-Filho

Discipline of Operative Technique, Department of Surgery, Federal University of Rio Grande do Norte, Brazil

irami.filho@uol.com.br

Gastroenterology Surgery Laparoscopic surgery

Dr. Irami Araújo-Filho graduated with a doctorate in Health Sciences from the Federal University of Rio Grande do Norte (2007) and a post-doctoral degree in Health Sciences from UFRN (2013), in addition to a Ph.D. from the University of Sorbonne/Paris Diderot/Experimental Surgery (2017/2018). He is currently Associate Professor IV of the Discipline of Operative Technique in the Department of Surgery at the Federal University of Rio Grande do Norte. He has experience in the area of medicine, with an emphasis on general surgery, gastroenterology, and oncology, acting mainly in the following lines of research: infection in surgery, intercurrent factors in wound healing, biodistribution of radionuclides, experimental models of osteoporosis, intestinal ischemia and reperfusion and solid organs, experimental model of bariatric surgery. 

Jian-Jun Li

Division of Dyslipidemia, State Key Laboratory of Cardiovascular Disease, Fu Wai Hospital, National Center for CVDs, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100037, China

lijianjun938@126.com

Cardiology Cardiovascular diseases Coronary Angiography Dyslipidemia hypertension

Jian-jun Li, Chief Physician. Former Deputy of the Coronary Heart Disease Center, Deputy Director of the Internal Medicine Management Committee, Director of the Dyslipidemia and Cardiovascular Disease Diagnosis and Treatment Center, and Director of Ward 51. He was formerly a member of the Expert Committee of the National Cardiovascular Center and is now the Executive Director of the International Atherosclerosis China Chapter, a member of the European and American Society of Cardiovascular Diseases (FESC/FACC), and a board member of the Asia Pacific Alliance for Metabolic and Cardiovascular Diseases. He is committed to the clinical diagnosis and pathogenesis of dyslipidemia and coronary heart disease and has completed more than 20 research projects, including national and provincial funds.

Jianhong Zhong

Department of Hepatobiliary Surgery, Guangxi Medical University Nanning, China

zhongjianhong66@163.com

Hepatic surgery Hepatitis B Hepatobiliary surgery Hepatocellular Carcinoma

Jian-Hong Zhong, MD, Ph.D., is a surgeon at the Department of Hepatobiliary Surgery of Guangxi Medical University Cancer Hospital, China. He completed his clinical research training at Guangxi Medical University Cancer Hospital and basic research training at the University of Illinois at Chicago. With broad research interests in hepatobiliary tract cancer and a major focus on hepatocellular carcinoma, he has published many full articles and reviews in peer-reviewed journals. As a peer reviewer, he has helped many journals review a lot of manuscripts. With his expertise in basic and clinical research on hepatocellular carcinoma, he has established a series of platforms for preclinical evaluation of the diagnostics and therapeutics of hepatocellular carcinoma and therapeutic modalities for patients with hepatocellular carcinoma.

Jitao Wang

Hebei Provincial Key Laboratory for Liver Cirrhosis and Portal Hypertension, Xingtai People’s HospitalHebei Provincial Key Laboratory for Liver Cirrhosis and Portal Hypertension, Xingtai People’s Hospital, Hebei, China

wangjt302@163.com

Artificial intelligence Cirrhosis Portal hypertension Liver cancer

Dr. Wang Jitao is the deputy director of the Hebei Provincial Key Laboratory of Liver Cirrhosis and Portal Hypertension. He graduated from Southeast University School of Medicine with a doctorate degree. His scientific interests are basic and clinical translational research on liver cancer and cirrhosis. He has published more than 50 SCI papers, including Journal of Hepatology, Gut, Clinical Gastroenterology and Hepatology, etc.  He was fund by the Provincial Natural Science and Provincial Key R&D Plans, and won the prize of the Hebei Province Science and Technology Progress Award and the Hebei Province Medical Science and Technology Progress Award.

Jiye Yin

Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, 410078, China.

yinjiye@csu.edu.cn

Clinical Pharmacology Personalized medicine Pharmacogenomics

Dr. Ji-Ye Yin is a professor at the Institute of Clinical Pharmacology, Xiangya Hospital, Central South University, and the vice director of the Hunan Key Laboratory of Pharmacogenetics. He completed his doctoral degree in the Department of Pharmacy, Central South University, China (2005.9–2011.12). He has published over 200 peer-reviewed articles and eight books. Professor Yin’s group focuses on Personalized Medicine, Clinical Pharmacology, and Pharmacogenomics. He was awarded the CNPHARS-SEVIER Young Investigator Award in Pharmacology. His research was supported by more than 20 foundations, including the Natural Science Foundation in China and the Distinguished Young Science Foundation from Hunan Province.

 

John Francis Mayberry

Department of Gastroenterology, Nuffield Hospital, Scraptoft Lane, Leicester LE5 5HY, UK

johnfmayberry@yahoo.co.uk

achalasia coeliac disease Epidemiology inflammatory bowel disease Public health Screening

Prof. John Francis Mayberry is a practicing physician and gastroenterologist in the private sector and was a consultant within the NHS for 25 years. His interests have been in inflammatory bowel disease, coeliac disease, oesophageal disorders, peptic ulcer disease, and colorectal cancer. He is also experienced in diagnostic and therapeutic endoscopy.

In addition, he led a research group for a similar period. Their main interests have been in ethnic minority health care, better patient information, and the aetiology of chronic gastrointestinal disease.

He was an editor of the Postgraduate Medical Journal and is on the editorial board of a number of journals. This has given him an interest in the ongoing education of doctors, clinical audits, and research fraud.

His law degrees and experience as a barrister helped him to crystallise clinical and research expertise into the setting of being an expert in clinical disputes, negligence, and insurance-related problems.

Kai Xiao

National Chengdu Center for Safety Evaluation of Drugs and National Clinical Research Center for Geriatrics, West China hospital, Sichuan University, Chengdu 610041, China

xiaokaikaixiao@scu.edu.cn

Anti-cancer drug Experimental therapeutics Tumor evolution Tumor microenvironment

Prof. Kai Xiao received his PhD in Pharmacology and Toxicology from Sichuan University in 2009. He completed his postdoctoral training and was then appointed as an Assistant Project Scientist at the University of California, Davis. Since 2014, he has been a full professor at the Precision Medicine Center, West China Hospital, Sichuan University, China. He has published over 80 peer-reviewed papers in internationally renowned journals. His research expertise includes cancer pharmacology, targeted drug delivery, and precision oncology. His current research interests mainly focus on the study of tumor evolution, anti-cancer drug resistance, and the discovery of new targets using clinically relevant tumor organoid and PDX models, as well as the development of smart biomaterials for precision delivery of anti-cancer drugs and genes.

Lance Dworkin

Department of Medicine, University of Toledo College of Medicine and Life Sciences, Toledo, OH 43606, USA

Lance.Dworkin@UToledo.edu

hypertension Kidney disease

Dr. Lance Dworkin conducts laboratory research on the mechanisms of progressive kidney failure and its prevention. He is also a clinical investigator and was the study chair for the CORAL trial, a large, multicentered, and randomized clinical trial funded by NHLBI that compared outcomes in patients with atherosclerotic renal artery stenosis (ARAS) treated medically with those who also receive stent revascularization. The results of the CORAL trial were published in 2014 in the New England Journal of Medicine.

Dr. Dworkin has published over 100 articles on a variety of topics in kidney disease and hypertension, including mechanisms of kidney inflammation and fibrosis and the outcomes and therapy of patients with ARAS. He has also authored more than 50 book chapters and review articles focusing on topics such as renal microcirculation, glomerular hemodynamics in health and disease, as well as mechanisms of acute and chronic kidney injury.

Lei Cheng

Department of Otorhinolaryngology & Clinical Allergy Center, The First Affiliated Hospital, Nanjing Medical University, 300 Guangzhou Road, Nanjing 210029, China

chenglei@jsph.org.cn

Allergen immunotherapy Allergic rhinitis Nasal polyps Noncoding RNA Probiotics SNPs Tinnitus

Prof. Lei Cheng works at the Department of Otorhinolaryngology & Clinical Allergy Center at the First Affiliated Hospital and the International Centre for Allergy Research, Nanjing Medical University, Nanjing, China. His main research directions are as follows: susceptibility gene of allergic rhinitis and their interaction with environmental factors, immunoregulatory function of probiotics and their mechanism of action in the prevention and treatment of allergic rhinitis, clinical pathology and immunological mechanism of non-allergic rhinitis, chronic rhinosinusitis, and nasal polyps, and functional nasal endoscopic sinus surgery minimally invasive technology.

Lieuwe Bos

Department of Intensive Care Medicine, Amsterdam University Medical Centers, Amsterdam, the Netherlands

l.d.bos@amsterdamumc.nl

Infectious diseases Intensive care medicine Pulmonology

Lieuwe Bos, Ph.D., focuses on precision medicine approaches to the treatment of lung injury due to inflammation and infection. He uses non-invasive diagnostic tools to classify patients into subphenotypes and target the subphenotypes with specific treatments

Linda Cox

Department of Medicine, Nova Southeastern University, Ft. Lauderdale, FL, USA

lscoxmd@gmail.com

Dermatology Immunology Allergy Asthma Biologics in the treatment of allergic conditions Conjunctivits Food allergy Internal medicine Rinitis Sinusitis

Dr. Linda Cox is an allergist in solo private practice in Fort Lauderdale and a clinical associate professor of medicine at Nova Southeastern University. Dr. Cox attended medical school at Northwestern University in Chicago and completed her fellowship in allergy and immunology at the National Jewish Center in Colorado. She is a member of the American Academy of Allergy Asthma & Immunology’s (AAAAI) Board of Directors and began her term as President of the American Academy of Allergy Asthma & Immunology on February 25, 2013. She has promoted standardization of allergy skin testing and allergen immunotherapy practice through the work of the JTFPP and IT/AD/ST, which resulted in the development of standardized immunotherapy, skin tests, instructions, and consent forms. She is currently co-chair of the WAO Immunotherapy and Immunomodulator Committee.

Luca Testarelli

Department of Oral and Maxillofacial Science, Sapienza University of Rome, Rome, Italy

luca.testarelli@uniroma1.it

3D in dentistry Aesthetic dentistry Clinical dentistry Dental caries Dental materials Endodontics Esthetic dentistry Implantology Oral surgery Restorative dentistry

Professor Testarelli is an Associate at the 1st Faculty of Medicine and Surgery of the University of Rome “La Sapienza” since 2006 and has been a Dentist in the Dental Clinic of Policlinico Umberto I’s Hospital of Rome since 2011. He completed a Ph.D. with the highest marks at the University of Rome “La Sapienza” in 2004 and obtained a Specialization Diploma in Orthognathodontics at the University of L’Aquila in 2008. Professor Testarelli is a member of several scientific national and international societies, particularly the European Society of Endodontology (ESE), and is an Active member of the Accademia Italiana di Endodonzia (AIE) and the Società Italiana di Odontoiatria Conservatrice (S.I.D.O.C.). He also serves as a member of several editorial boards for dental scientific journals. Additionally, he holds positions as Professor of Dental Restorative and Endodontics at the School of Dentistry in Sapienza University of Rome, Professor of Oral Care in the School of Dental Hygienist in Sapienza University of Rome, and Professor of PhD Dentistry in Sapienza University of Rome.

Mahboob Alam

Baylor College of Medicine, Houston, Texas, USA

Mahboob.Alam@bcm.edu

Acute myocardial infarction Coronary artery disease Hypertrophic obstructive cardiomyopathy Interventional cardiology Ischemic heart disease Percutaneous coronary and peripheral intervention Peripheral arterial disease Valvular heart disease

Dr. Mahboob Alam has been working at Baylor College of Medicine as an Associate Professor in the Department of Medicine, Section of Cardiology, since 2012. Dr. Alam is a Fellow of the American College of Cardiology (FACC) and a Fellow of the Society of Cardiac Angiography and Interventions (FSCAI).

As an interventional cardiologist, Dr. Alam focuses on the management of coronary and peripheral artery disease. He is actively involved in taking care of patients with high-risk coronary artery disease requiring advanced mechanical circulatory support, including cardiogenic shock, complex anatomy, including chronic total occlusions, and heavily calcified plaques requiring coronary atherectomy, intravascular lithotripsy, or mechanical thrombectomy.

Dr. Alam is involved in various multicenter clinical trials, enrolling patients at Baylor St. Luke's Medical Center, Houston, TX. Other interests include primary and secondary prevention of coronary artery disease, hypertrophic cardiomyopathy, and thromboembolic pulmonary arterial diseases.

When not providing clinical care, Dr. Alam dedicates his time to clinical research and has been an active voting member on various committees of the American College of Cardiology (ACC) and the Society of Cardiac Angiography and Interventions (SCAI).

Marc de Smet

Department of Ophthalmology ZNA Middelheim, Antwerp, Belgium

mddesmet1@mac.com

Ophthalmology

Prof. Marc de Smet is the former head of the Department of Ophthalmology at the University of Amsterdam, the founder and head of MIOS sa, Lausanne, Switzerland, and the CMO – Preceyes bv, an ophthalmic robotics company. His research topics are ocular inflammation, ocular pharmacology, ocular imaging (retinal and inflammatory disorders), retinal surgery, and robotics. He has spearheaded the development of ocriplasmin for ophthalmic applications (patent holder) and the use of intraocular methotrexate for ocular lymphoma. He is one of the first individuals to use transverse OCT. He initiated the development of the Preceyes robot for eye surgery, the first robot ever to perform high-precision intraocular surgery.

Marc Jeschke

Hamilton Health Sciences Centre, Hamilton, Canada

Surgeon, Ross Tilley Burn Centre

Hamilton Health Sciences and Mc Master University

President, Canadian Burn Association

Professor, University of Toronto, Department of Surgery and Plastic Surgery

marc.jeschke@hhsc.ca

Burn care Surgery Burn wounds Plastic surgery

Prof. Marc Jeschke has world-renowned expertise in the field of translational research. He is a research leader with a proven ability to attract funding and grants from various national programs and agencies to advance innovative medical care in burns. Under his direction since 2010, the Ross Tilley Burn Centre (RTBC) at Sunnybrook Health Sciences Centre has become a leading surgical and burn care institution in North America. Prior to being the Director of the RTBC, Dr. Jeschke held faculty positions at the University of Texas Medical Branch and Shriners Hospital for Children. In addition to his work as a surgeon, he coordinated research activities with a focus on increasing productivity and obtaining grants. Dr. Jeschke became an MD in Germany, moved to the United States, and obtained a Master of Medical Science degree at the University of Texas. He then returned to Germany to complete his PhD (Habilitation) in Experimental Surgery at the University of Regensburg in Bavaria.

 

Marc Jean Berna

Hôpitaux Robert Schuman, 2540 Luxembourg, Luxembourg

marc.berna@hopitauxschuman.lu

Gastroenterology Endoscopic ultrasound Fine needle aspiration Pancreatic cancer

Dr. Marc Jean Berna is the CEO of Hôpitaux Robert Schuman. Dr. Berna has special clinical interests in interventional endoscopy, advanced resection techniques (EMR, ESD), clinical pancreatology, gastrointestinal oncology, and IBD. Current research projects include personalised treatment approaches in gastrointestinal cancer, signal transduction in the pancreas, and pancreatic cancer.

Marcel Dirkes

Quin.md, Amsterdam, the Netherlands

marceldirkes@gmail.com

Clinical research

Marcel Dirkes is from the Department of Surgery (Surgical Laboratory), Academic Medical Center, University of Amsterdam. His research topic is clinical research.

Marcello Covino

Emergency Medicine, Università Cattolica del Sacro Cuore, Rome, Italy

marcello.covino@unicatt.it

Pathology Emergency medicine Internal medicine

Marcello Covino, MD, Ph.D., is an assistant professor at Emergency Medicine, Università Cattolica del Sacro Cuore, Rome, Italy. He has broad research interests in medical and surgical emergencies in older adults, acute diverticulitis, acute pancreatitis, sepsis, infection in an emergency, procalcitonin, trauma, head trauma, early warning scores, and COVID-19. With his expertise in clinical activity, he has published 111 papers in peer-reviewed journals from 1993 to the present and more than 300 abstracts presented in national and international meetings. He is a member of the Italian Society of Emergency Medicine (SIMEU) and the Italian Society of Internal Medicine (SIMI).

Martin Michel

Department of Pharmacology, Johannes Gutenberg University, Mainz, Germany

marmiche@uni-mainz.de

Nephrology Pharmacology and toxicology

Martin C. Michel is a physician trained in experimental and clinical pharmacology in Essen (Germany) and San Diego (California). He headed the Nephrology and Hypertension Research Laboratory at the University of Essen (Germany; 1993–2002), the Department of Pharmacology and Pharmacotherapy at the University of Amsterdam (The Netherlands; 2003–2011), and was Global Head of Product and Pipeline Scientific Support at Boehringer Ingelheim (Germany; 2011–2016). His current affiliations include being a Professor of Pharmacology at the Johannes Gutenberg University in Mainz (Germany; since 2012) and being a Senior Partner at the Partnership for the Assessment and Accreditation of Science (PAASP, Heidelberg, Germany; since 2016). His research focuses on urogenital and cardiovascular pharmacology, where he has published more than 500 peer-reviewed articles cited >34,000 times, yielding an h-index of 93. He is an editor or serves on the board of many pharmacological journals, including Mol Pharmacol and Pharmacol Rev. He is a member of the European Academy of Sciences (Academia Europaea) and an honorary fellow of the British Pharmacological Society.

Merete Haedersdal

Department of Dermatology, University of Copenhagen, Bispebjerg Hospital, Copenhagen, Denmark

mhaedersdal@dadlnet.dk

Dermatology

Prof. Merete Haedersdal leads a research team of 10 researchers, focusing on translational medicine in laser dermatology. Merete is a consultant in dermatology at Bispebjerg Hospital and a clinical professor at the University of Copenhagen, Denmark. She is a visiting scientist at the Wellman Center for Photomedicine, Massachusetts General Hospital, and Harvard Medical School, collaborating with Professor R. Rox Anderson and his team to develop better treatments for patients with skin cancer by means of lasers and light-based techniques.

Michael Schulder

Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, USA

mschulder@northwell.edu

Brain tumors History of neurosurgery Stereotactic neurosurgery Stereotactic radiosurgery

Dr. Michael Schulder is a professor and vice chair of the Department of Neurosurgery at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. He is the program director of neurosurgical residency training at the Zucker SOM, director of the Brain Tumor Center of the Northwell Neuroscience Institute, and co-director of the Center for Stereotactic Radiosurgery at the Northwell Cancer Institute. Dr. Schulder runs Northwell’s clinical trials programs for patients with brain tumors. He has been the principal investigator on numerous trials, pioneering the use of various methods of image guidance in neurosurgery, including functional and intraoperative MRI. His particular areas of focus include image-guided brain tumor surgery, stereotactic radiosurgery, and functional neurosurgery, on which he has published over 130 peer-reviewed papers along with numerous book chapters and abstracts. Dr. Schulder is on the editorial board of several major neurosurgical journals.

Michiel Sinaasappel

Department of Clinical Physics and Instrumentation, Netherlands Cancer Institute, Amsterdam, the Netherlands

m.sinaasappel@nki.nl

Nuclear medicine Oncology Radiology and radiotherapy

Michiel Sinaasappel practices in Amsterdam, Netherlands. His top areas of expertise are Pulmonary Edema and Laryngectomy.

His clinical research consists of co-authoring 12 peer-reviewed articles in the past 15 years.

Milan Brazdil

Brno Epilepsy Center, First Department of Neurology, St. Anne's University Hospital and Faculty of Medicine, Masaryk University, Brno 656 91, Czech Republic

milan.brazdil@fnusa.cz

Neurology Epilepsy

Milan Brázdil, M.D., Ph.D., FRCP, is a Professor of Neurology and Chairman of the Department of Neurology at the Faculty of Medicine, Masaryk University and St. Anne´s University Hospital, Brno, Czech Republic, and group leader of the Behavioral and Social Neuroscience Research Group at CEITEC MU. He is a co-founding member of Brno Epilepsy Center (1993), where he currently serves as the director. Milan Brázdil is the past president of the Czech League Against Epilepsy and the current president of the Czech Society for Clinical Neurophysiology. He authored more than 300 original papers published in peer-reviewed journals (PubMed 196). His SCI citing index is 3084 and his H-index is 31. Milan Brázdil´s main clinical and research interests are epilepsy surgery, invasive electrophysiology, and behavioral neuroscience. He has received research funding from national and European grant agencies and has been the principal investigator for several clinical trials in epilepsy.

Milka Sokolovic

European Food Information Council, Brussels, Belgium

Milka.Sokolovic@eufic.org

Nutrition

Dr. Milka Sokolovic holds a degree in Biology from the University of Belgrade and a Ph.D. in Medicine from the University of Amsterdam. Through her research and academic roles at the Universities of Belgrade and Amsterdam and her leadership roles at EUFIC and ENLP, she has developed remarkable expertise in scientific research, communication, and strategic partnerships. Milka instigates alliances and forges partnerships while advocating for equitable solutions to European public health challenges, insisting on the vital role of civil society in reaching those solutions.

Mushfiquddin Khan

College of Medicine, Medical University of South Carolina, Charleston, SC 29425, USA

khanm@musc.edu

Cerebral ischemia and reperfusion Lipid signaling in neurodegenerating and demyelinating diseases Neuropharmacology of CNS trauma Permanent ischemia Role of oxidative stress and reactive lipids in neurodegenerative diseases Spinal cord injury Stroke Traumatic brain injury

Prof. Mushfiquddin Khan's research interest is to investigate the neuropharmacology of CNS trauma with a major focus on stroke (cerebral ischemia and reperfusion, IR, and permanent ischemia), traumatic brain injury (TBI), and spinal cord injury (SCI). The investigations have targeted both neuroprotection and neurorestoration for optimal functional recovery of neurobehavioral and cognitive functions following stroke. His bioorganic background and neuropharmacology training prepared him to study design, prepare and administer drugs to animals, and monitor their efficacy. These studies helped him to develop expertise in animal models (rat and mouse) of acute or chronic brain injury (IR and TBI), evaluation of neurobehavioral and neurological functions, and measurements of physiologic parameters as well as cerebral blood flow and physiological parameters. To understand the neurorestoration mechanisms, he devoted my efforts to investigating the role of proteases and lipases in neuronal cell death. He remained focused on neurovascular protection and cross-talk between endothelial cells, neurons, and glial cells.

Narci Teoh

Department of Gastroenterology and Hepatology, The Australian National University, Canberra, Australia

narci.teoh@anu.edu.au

Experimental medicine Hepatology

Narci Teoh is a Professor of Medicine at the Australian National University Medical School and a Senior Staff Specialist in Gastroenterology and Hepatology at The Canberra Hospital. She is also engaged in part-time private practice at GastrotrACT Gastroenterological Services, Brindabella, and Mugga Warra Endoscopy Centres in Garran, Canberra.

Her clinical interests in gastroenterology include coeliac disease as well as digestive tract cancers, especially in the prevention, screening, and management of cancers that arise in the large bowel and liver. She also has expertise in the care and treatment of patients with hepatitis B and fatty liver disease and is committed to patient education and advocacy in these areas.

Nazia Chaudhuri

School of Medicine, University of Ulster Faculty of Life and Health Sciences, Londonderry, Derry, UK

nazia.chaudhuri@nhs.net

Interstitial lung disease Lung diseases Pulmonary sarcoidosis Sarcoidosis

Dr. Nazia Chaudhuri is a senior clinical lecturer at Ulster University and is the leader of the Northern Ireland ILD network. She graduated from the University of Leeds with an honours degree in medicine and a BSc in honours in genetics. She performed a Ph.D. and published her work looking at cellular interactions and signalling in response to infection and air pollution. She is a respiratory physician with a specialist interest in interstitial lung disease (ILD). Dr. Chaudhuri has published her experience in prescribing antifibrotics and delivering MDT care and has presented over 40 abstracts pertaining to IPF, antifibrotics, and the importance of a multi-disciplinary team approach at all major respiratory conferences. She is a collaborator on a number of grants and has co-authored over 50 peer-reviewed articles.

Nicholas Kounis

Department of Medicine, University General Hospital of Patras, Rio, Greece

ngkounis@otenet.gr

Allergic myocardial infarction Angina and Allergy Hypersensitivity and ischemic cardiac disease Kounis syndrome

Prof. Nicholas G. Kounis was born in Patras, Greece, and graduated as the first of all medical students from Athens University Medical School after five and a half years (the course usually lasts six years). He moved to the United Kingdom and worked for ten years in salaried posts as a house officer, senior house officer, registrar, clinical tutor, and senior registrar, initially in medicine and afterward in cardiology. Following his work abroad, he returned to Greece, where he worked as a consultant cardiologist at Patras University Medical School for ten years and, afterward, as a Professor of Medicine at Patras Highest Institute of Education and Technology until now. During his career, he has served as a reviewer for more than 500 peer-reviewed PubMed medical journals. And he has authored more than 410 PubMed-included scientific papers in English medical literature. Among them are three clinically pioneering medical descriptions: Iliacus Hematoma Syndrome and Cardiopathia Fantastica. He is also the founder of Kounis Syndrome. Kounis syndrome is considered today to be nature’s own experiment and a magnificent natural paradigm showing novel ways to recognize and prevent acute coronary syndromes.

Niramol Savaraj

Sylvester Comprehensive Cancer Center, Bascom Palmer Eye Institute, University of Miami Health Systems, Miami, FL, USA

NSavaraj@med.miami.edu

Tumor metabolism and signaling

Niramol Savaraj, MD, is an oncologist at the Miami VA Healthcare System and a full professor in the Department of Medicine at the University of Miami. She is an expert in tumor metabolism, specifically in the field of drug resistance. She has published extensively in this field.

Pavlos Zarogoulidis

Director of Pulmonary Department, “General Clinic Euromedica” Private Hospital, Thessaloniki, Greece

pzarog@hotmail.com

Development and therapy Drug design Interventional pulmonology Lung cancer Pharmacology

Pavlos Zarogoulidis, M.D., Ph.D., is the Director of the Pulmonary Department, “General Clinic Euromedica” Private Hospital, Thessaloniki, Greece. Dr. Pavlos Zarogoulidis performs diagnosis for lung cancer with bronchoscopy, radial and convex probe endobronchial ultrasound, and medical thoracoscopy. He has more than 425 publications and is collaborating with several departments in the USA, Europe, and China. Dr. Pavlos Zarogoulidis is a strong believer in the close collaboration between different countries and between oncologists, pulmonary physicians, radiotherapists, and thoracic surgeons.

Pnina Fishman

Can-Fite BioPharma, Petah Tikva 49170, Israel

Pnina@canfite.co.il

Wnt and NF-κB signaling pathways A3 adenosine receptor Cancers Cytokines inflammatory

Dr. Pnina Fishman is the scientific founder of Can-Fite BioPharma. She was previously a professor of Life Sciences at Bar-Ilan University in Israel. She has also headed the Laboratory of Clinical and Tumor Immunology at the Felsenstein Medical Research Institute, Rabin Medical Center, Israel. Dr. Fishman has authored or co-authored over 200 publications and presented her research findings at many major scientific meetings. Dr. Fishman is a world leader in the research of adenosine receptors. Her scientific work focuses on the development of small-molecule drugs that target the A3 adenosine receptor, which is highly expressed in cancer and inflammatory cells. This scientific work has gained recognition as one of the leading approaches for new-generation therapies for liver diseases.

Raffaele Addeo

Medical Oncology Unit, San Giovanni di Dio Hospital, 80027 Frattamaggiore, Naples, Italy

raffaele.addeo@aslnapoli2nord.it

Immunotherapy Brain tumors Chemotherapy Clinical research Head and neck cancer Patient centered care Quality of life Rare cancer Target therapy

Dr. Raffaele Addeo is the Head of the Division of Oncology at the Hospital “San Giovanni Di Dio” Frattamaggiore (NA), ASLNA2NORD, Italy. He graduated with an MD from the Second University of Naples. He did postgraduate oncology training at the Second University of Naples. He obtained a PhD in Biochemical and Biotechnological Sciences from the University of Campania Luigi Vanvitelli in Naples, Italy. His clinical research interests are in the treatment of cancer, especially brain cancer and head and neck cancer. He is involved in several multidisciplinary projects and studies for the treatment of head and neck cancer. Dr. Addeo published more than 130 scientific papers in journals, including translational cancer research and clinical oncological research.

 

Raimundas Lunevicius

Department of General Surgery, Liverpool University Hospitals NHS Foundation Trust, Lower Lane, Liverpool L9 7AL, UK

raimundas.lunevicius@liverpoolft.nhs.uk

Clinical outcomes Descriptive epidemiology Emergency gastrointestinal surgery Gallbladder surgery Global health Subtotal cholecystectomy Trauma surgery

Prof. Dr. Raimundas Lunevicius, qualified from Vilnius University (Lithuania), worked in the University Emergency Care Hospital between 1991 and 2010. He completed three fellowship programmes: Monbushou at Nagoya University and Aichi Cancer Centre (Japan, 1998–2000), Fulbrigt-Humphrey at Johns Hopkins University Bloomberg School of Public Health with clinical affiliation with R. R. Adams Cowley Shock Trauma Centre (USA, 2008–2009), and King’s College Hospital London (2010–2012). In 2012, he accepted the offer to work as a consultant general surgeon for the Aintree University Hospital and Major Trauma Collaborative, Liverpool. His research and audit interests are in difficult gallbladder management, acute care surgery, liver injury, trauma, and global health. A bibliography of his publications includes 234 refereed articles, 71 abstracts, three monographs, two doctoral dissertations, two book chapters, one edited book, multiple presentations, and lectures (by August 15, 2023). His h-index is 67. He is the collaborator for the Global Burden of Disease Study, IHME, University of Washington (2012–to date), and Global Surgery, University of Birmingham, UK (2020–to date). He has been a UK Trauma Audit and Research Network (TARN) board member since 2020. He is a clinician, surgeon, supervisor, researcher, auditor, reviewer, editor, organiser, and lecturer. 

Riccardo D’Ambrosi

IRCCS Orthopedic Institute Galeazzi, Via Galeazzi 4, 20161 Milan, Italy

riccardo.dambrosi@hotmail.it

Anterior cruciate ligament arthroscopy Knee Meniscus Sports medicine

Dr. Riccardo D’Ambrosi currently works in the CASCO Department at IRCCS Ospedale Galeazzi-Sant’Ambrogio in Milan and is a researcher at the University of Milan. He is mainly involved in ligament knee surgery (ACL, PCL, and multi-ligamentous knee surgery), with particular attention to sports medicine and regenerative medicine (scaffold implantation, cartilage regeneration, and infiltrative treatments). Dr. D’Ambrosi has more than 110 impacted publications on PubMed, most of which are clinical practice and systematic reviews focusing on knee surgery with numerous international collaborations. In 2016, he was awarded the best orthopedic oral communication at the National Shoulder and Elbow Congress (SICSeG). Furthermore, he was awarded the best poster in 2018 and 2019 at the SIOT (Società Italiana di Ortopedia e Traumatologia) national congress, and in 2021, he won the Best Knee Presentation Pre-Meeting Virtual Siot Congress 2021. Recently, he was a coauthor for the poster and won a prize at the ESSKA Congress.

Richard Rosen

The New York Eye & Ear Infirmary, New York, NY, USA

RRosen@nyee.edu

Ophthalmology

Dr. Richard Rosen is a vitreoretinal surgeon and consultant at the New York Eye and Ear Infirmary, where he serves as the Vice Chairman and Director of Ophthalmology Research, as well as the Surgeon Director and Chief of Retinal Services. Dr. Rosen is a Professor of Ophthalmology at the Icahn School of Medicine at Mount Sinai and a Visiting Professor in Applied Optics at the University of Kent in Canterbury, UK. He received his bachelor’s degree in psychology and anthropology at the University of Michigan and his MD from the University of Miami School of Medicine. He also did graduate work in psychophysics in the Laboratory of Neuromagnetism at New York University. He worked for several years as a professional photographer in New York City, with an interest in ophthalmic and scientific photography.

Robert Barkin

Department of Anesthesiology, Rush Medical College, Chicago, IL USA

Departments of Pharmacology and Family Medicine, Rush University, Chicago, IL, USA

Robert_Barkin@rush.edu

Geriatrics Acute pain Chronic pain Fibromyalgia Migraine headache Neuropathic & nociceptive pain Postoperative pain Psychopharmacology

Dr. Robert L. Barkin is a Professor of Anesthesiology, Pharmacology, and Family Medicine at Rush University Medical Center in Chicago, Illinois. He is also a clinical pharmacologist in a collaborative practice with five anesthesiologist physician pain specialists at the NorthShore University Health System Department of Anesthesiology Pain Center of Skokie and Evanston Hospitals in Illinois. His extensive practice is both outpatient and inpatient for all pain syndromes. Dr. Barkin designs patient-specific pharmacotherapeutic treatment plans. Following graduation from St. Louis College of Pharmacy, Dr. Barkin earned a master's degree in Business Administration in Healthcare Administration from DePaul University in Chicago, Illinois. He then earned his Doctor of Clinical Pharmacy degree from Purdue University in West Lafayette, Indiana. Dr. Barkin is the author of more than 150 abstracts, CD-ROM programs, textbook chapters, and peer-reviewed articles. He was a senior editor for the American Journal of Therapeutics. He also serves as a reviewer for over 30 peer-reviewed journals and on the Editorial Board of 20 peer-reviewed journals. He is frequently invited to speak on a wide variety of topics at both national and international conferences and seminars. He is a Diplomate of the American Academy of Pain Management, a Fellow of the American College of Clinical Pharmacology, and a Diplomate of the American Board of Forensic Medicine, Examiners, and Psychologic Specialties in Psychopharmacology. Dr. Barkin was granted scientific status by the American Academy of Pain Medicine. He was also granted an Overseas Fellow of the Royal Society of Medicine in England. Dr. Robert L. Barkin's research interests are pain-acute and chronic postoperative pain, fibromyalgia, migraine headaches, neuropathic and nociceptive pain, and psychopharmacology.

Robert Garfield

Department of Ob/Gyn, College of Medicine, University of Arizona, Phoenix, AZ 85721, USA

drrobertgarfield@gmail.com

Cardiovascular physiology Cell signaling Fetal growth restriction hypertension Obstetrics Pharmacology Preeclampsia

Prof. Robert Garfield is an American academic and author with formal training in pharmacology (PhD, University of Alberta, Canada). He has collaborated globally with leading scientists and clinicians and trained many exceptional young scientists. He has held positions as a full professor in the Departments of Obstetrics and Gynecology at McMaster University (Hamilton, Ontario), the University of Texas Medical Branch (Galveston, Texas), St. Joseph’s Hospital and Medical Center (Phoenix, Arizona), Creighton University, and recently completed four years of study in obstetrics at Guangzhou Women and Children’s Hospital (Guangzhou, China). He is a professor at the University of Arizona College of Medicine in Phoenix. He maintains an active research program focused on pregnancy from conception to delivery, including extensive studies of the electrical activity of the uterine muscle, which controls uterine contractions during the term and preterm labor, and dilation of the cervix.

Roy G. Beran

Neurology Department, Liverpool Hospital, Liverpool, Australia

South Western Clinical School, University of New South Wales, Sydney, Australia

Ingham Institute for Medical Research, South Western Sydney Area Health Service, Sydney, Australia

School of Medicine, Griffith University, Southport, Australia

roy@royberan.com

Concussion Epilepsy Legal medicine Medical education Neuroepidemiology

Prof. Roy G. Beran is a consultant neurologist and accredited sleep physician who works in legal medicine, military medicine, and aviation medicine. His research interests include concussion, epilepsy, legal medicine, stroke, sleep, neuroepidemiology, neurological imaging, and medical education. His qualifications include MBBS, MD, FRACP, FRACGP, and Grad. Dip. Tertiary Ed., Grad. Dip. Further Ed., FAFPHM, FACLM, FRCP, FAAN, FACBS, B Leg. S, MHL, and FFFLM (Hon). He has registered with the Australian Health Practitioner Regulation Agency (AHPRA), which includes neurology, public health, and sleep medicine. He was a Designated Medical Examiner for the Civil Aviation Safety Authority, a medical assessor for dispute resolution for the State Insurance Regulatory Authority, and an assessor for the Workers Compensation Commission of New South Wales (NSW). He is a conjoint professor of medicine at the University of NSW, a professor in the School of Medicine at Griffith University, Queensland, a conjoint professor at a medical school at Western Sydney University, and a professor and chair at Sechenov Moscow 1st State University, Moscow, Russia. Following Russia’s invasion of Ukraine, he refused to resign from Sechenov University. He was the inaugural Visiting Professor at the International Research Institute of Health Law Sciences at the Southern Medical University, Guangzhou, China, and has been personally invited to apply for a professorial position at the university in Shanghai by the dean of the newly established faculty, Professor Hongjie Man. His research interests include concussion, epilepsy, legal medicine, stroke, sleep, neuroepidemiology, neurological imaging, and medical education.

Sacha Zeerleder

Department of Hematology, Division of Internal Medicine, Luzerner Kantonsspital, Luzern, and University of Berne, Bern, Switzerland

sacha.zeerleder@insel.ch

Hematology Oncology Transfusion Transplantation

Prof. Sacha Sergio Zeerleder, MD, Ph.D., received his MD from the University of Berne (Switzerland) in 1997. He completed the training as an internist hematologist at the University Hospital of Bern, Switzerland, and at the Academic Medical Center AMC in Amsterdam, the Netherlands. From 2010 to July 2018, Prof. Zeerleder worked as a staff hematologist at the Academic Medical Centre AMC and a principal investigator at Sanquin Research in Amsterdam. At the AMC, he was the director of the stem cell transplantation program and the medical head of the special hematology laboratory and the transfusion laboratory. In 2016, he was appointed full professor of immunohematology at the University of Amsterdam. Since August 2018, he has been the chief physician at the University Hospital of Bern, Switzerland. He is responsible for the transfusion service and the apheresis unit. He is also the director of the program Cellular Therapies and vice director of the Center of Hemato-oncology as part of the University Cancer Center Inselspital (UCI). In July 2019, he received the “venia docendi” and his “associate professorship” from the medical faculty at the University of Bern. The main research interest of Prof. Sacha Zeerleder lies in the role of innate immunity in hematological diseases.

Salvatore Giordano

Deputy Chief of Plastic and General Surgery, Professor of Surgery Turku University Hospital, University of Turku, Finland

salgio@utu.fi

Abdominoplasty Breast augmentation Breast reconstruction Breast reduction Diastasis Plastic surgery

Salvatore Giordano, MD, Ph.D., FACS, is a Professor of Surgery at the Department of Plastic and General Surgery at Turku University Hospital, Finland. He completed his MD in Facoltà di Medicina e Psicologia in the Sapienza Università di Roma

 in Rome (1999-2005), Clinical Fellowship in Microsurgery (Plastic Surgery) in Broomfield Hospital, UK (2014-04-2014-06), Specialist in Plastic Surgery (Plastic and General Surgery) -Faculty of Medicine, University of Turku in Finland (2011-2014), Post-Doctoral Fellowship (Plastic Surgery), University of Texas MD Anderson Cancer Center in USA (2015-2016), PhD-University of Turku in Finland (2014-present ), Docent in Experimental Surgery-University of Turku in Finland (2015-present), Docent in Plastic Surgery-University of Turku in Finland (2019-present), Professor (Surgery)-University of Turku in Finland (2020-present). He has broad research interests in medical and surgical emergencies in breast reconstruction, breast augmentation, breast reduction, mastopexy, breast lift, abdominoplasty, diastasis, and massive weight loss. He has published many full articles and reviews in peer-reviewed journals. As a peer reviewer, he has helped many journals review a lot of manuscripts. With his expertise in clinical activity, he has published 138 papers in peer-reviewed journals (H-index Scopus 26). He is the Deputy Chief of Plastic and General Surgery at Turku University Hospital.

Sandrine Florquin

Department of Pathology, Amsterdam University Medical Centers, Amsterdam, the Netherlands

s.florquin@amsterdamumc.nl

Nephrology Pathology

Dr. Sandrine Florquin (1965) received her MD degree from the Faculty of Medicine of the Universite Libre de Bruxelles (Belgium) in 1990, her “Thèse d’Agrégation de l’Enseignement Supérieur” from the same university in 1995, and her PhD degree (cum laude) from the University of Leiden in the Netherlands in 1997. In 1998, she was board-certified in the Netherlands in pathology and in 2001 in immunology. From 1991 to 1994, she was a Research Fellow of the Fonds National de la Recherche Scientifique in the Department of Immunology of Prof. M. Goldman, Université Libre de Bruxelles in Belgium, and the departments of Prof. B. Brenner and R. Cotran in Brigham and Women’s Hospital at Harvard University. Since 1998, Florquin has been a staff member of the Department of Pathology at the AMC. Her research is embedded in the Center for Immunology Amsterdam (CIA). She received several NWO grants (Clinical Fellowship, ASPASIA, and VIDI). In 2007, she was appointed Professor of Pathology at the University of Amsterdam. She is a member of the Scientific Board of the Dutch Kidney Foundation and of the ERA-EDTA.

Sher Ali Khan

Department of Internal Medicine, University of New Mexico, Albuquerque, USA

sheralikhan61@gmail.com

Addiction medicine Internal medicine Preventive medicine Primary care

Sher Ali Khan is from the University of New Mexico Health Sciences Center and the Department of Internal Medicine. His research topics are Addiction medicine, Internal medicine, Preventive medicine, and Primary care.

Shichun Lu

Faculty of Hepato-Pancreato-Biliary Surgery, Chinese PLA General Hospital, Beijing, China

lsc620213@aliyun.com

Oncology Surgery Hepatobiliary surgery Transplantation

Dr. Shichun Lu practices in Beijing, China. He is rated as an experienced expert by MediFind in liver transplants. Their top areas of expertise are liver cancer, hepatitis B, cirrhosis, hepatectomy, and liver transplants.

Shivendra Vikram Singh

Department of Surgery, St. Jude Children's Research Hospital, Memphis, TN, USA.

Shivendra.Singh@STJUDE.ORG

Cancer metabolism Immune cell metabolism Tumor microenvironment

Shivendra Vikram Singh, Ph.D., is currently working as a lead research scientist at St. Jude Children's Research Hospital to discover advanced therapeutics to treat pediatric catastrophic diseases.

His research areas are tumor development, genetic abnormalities, epigenetic alterations, and metabolic changes that occur and evolve throughout cancer progression and treatment. These changes can accelerate cancer progression, metastasis, and drug resistance. His future research will investigate the interaction between these alterations and oncogenic drivers during cancer pathogenesis. To accomplish this, his group will employ molecular techniques such as CRISPR, ATAC-seq, CHIP-seq, and RNA-seq, along with cellular and pharmacological methods and in vivo mouse models.

Shuqun Cheng

Department of Hepatic Surgery VI, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China

chengshuqun@aliyun.com

Oncology Surgery Hepatobiliary surgery Transplantation

Dr. Shuqun Cheng received a B.S. degree in 1989 from Wenzhou Medical University, Wenzhou, China, and master’s and Ph.D. degrees from the Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China. Then he entered the Eastern Hepatobiliary Surgery Hospital for postdoctoral training. He is currently the Director of the Department of Hepatic Surgery VI, Eastern Hepatobiliary Surgery Hospital, The Second Military Medical University. As a surgeon, he did almost 400 operations for liver cancer resection every year. Besides these, he has engaged in research into the basic science of liver cancer surgery and clinical problems, such as the mechanism of HCC tumor thrombus formation and comprehensive treatment for liver cancer.

Simon Rabkin

Department of Medicine, The University of British Columbia, Vancouver, Canada

simon.rabkin@ubc.ca

Clinical electrophysiology Heart failure Signal transduction and vascular disease

Dr. Simon Rabkin is a Professor of Medicine in the Division of Cardiology at the University of British Columbia (UBC). He graduated with an MD from the University of Manitoba. He did postgraduate training in internal medicine and cardiology at the University of Toronto, the University of Cincinnati, and Emory University. His research interests are in the determinants of cardiovascular disease and its therapy. He is especially interested in unraveling the causes of heart failure, cardiac arrhythmias, aortic aneurysms, and the interface between the brain and the heart. His research interests and activities have spanned the range of basic science, clinical investigation, clinical trials, and epidemiology. He has published almost 300 scientific papers or book chapters. He was the founding director of the Program in Experimental Medicine at the University of British Columbia, which is now one of the largest graduate programs in the Faculty of Medicine. He has served on many Canadian consensus conferences for the development of best practice guidelines for Canadian physicians. He is the current chair of the subcommittee on the pharmacologic management of patients with hypertension and cardiac disease for the Canadian Hypertension Education Program (CHEP). Dr. Rabkin is a past president of the Canadian Hypertension Society and was the President of the 23rd Scientific Meeting of the International Society of Hypertension in 2010.

Stavros Dimopoulos

Cardiac Surgery ICU, Onassis Cardiac Surgery Center, Athens, Greece

Cardiopulmonary Exercise Testing and Rehabilitation Laboratory, National Kapodestrian University of Athens, Athens, Greece

stdimop@med.uoa.gr

Acute kidney injury Cardiopulmonary exercise testing Cardiopulmonary rehabilitation programs Chronic heart failure ECMO ICU sonography Intensive care unit acquired weakness Left ventricle assist device Neuromuscular electrical stimulation Pulmonary arterial hypertension Sepsis

Dr. Stavros Dimopoulos received his PhD degree from the Medical School of the National Kapodistrian University of Athens (UOA), Greece, in 2008. Since 2016, he has been working as a Cardiac Surgery ICU Consultant at Onassis Cardiac Surgery Center in Athens, Greece and he is now the Cardiac Surgery ICU Director. He is the former President and founding member of the Greek Society of Ergospirometry, Exercise & Rehabilitation, Co-Director of the ECMO Center (ELSO) at Onassis Cardiac Surgery Center and member of scientific societies including ESICM/EACPR/Heart Failure Association/ESC/ELSO. He is currently reviewer for more than 60 international scientific peer-reviewed journals, for NIHR and member of the Editorial Board of more than 30 international peer-reviewed open-access scientific journals. He has coauthored in more than 90 papers in international peer-reviewed refereed journals, 9 chapters in books, and more than 150 abstracts in international congresses.

Stefano Palomba

Unit of Gynecology, Sant’Andrea Hospital of Rome, University Sapienza of Rome, Via Grottarossa 1039, 00189 Rome, Italy

prof.stefano.palomba@gmail.com

Infertility Ovulation induction PCOS Reproductive surgery

Prof. Stefano Palomba is from the Unit of Gynecology at Sant’ Andrea Hospital of Rome, University Sapienza of Rome, Italy. Prof. Palomba serves as the scientific secretary for various national and international congresses, meetings, and workshops in the gynecological endocrinology field. He is an active member of several national and international scientific societies. Prof. Palomba also contributes as a reviewer and commentator for numerous international scientific journals, showcasing his dedication as a researcher in the field of gynecologic endocrinology and publishing over 250 scientific articles in the most prestigious international journals with high impact factors.

Sumanta Saha

Independent Researcher, India

sumanta.saha@uq.net.au

Infectious diseases Pediatrics Statistics and epidemiology

Dr. Sumanta Saha is a physician and epidemiologist in infectious disease epidemiology, diabetes in children, and pregnancy. His publications include several first-authored publications on observational studies and evidence-synthesis research. He has experience peer-reviewing and handling several manuscripts in different journals.

Tony Kleijn

Department of Pathology and Medical Biology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands

t.g.kleijn@umcg.nl

Pathology

Dr. Tony Kleijn is a pathology resident at the University Medical Center Groningen (UMCG). He is on the board of the National Pathology Assistants Association (LPAV) to represent the interests of Dutch AIOS. He is also involved in various training and international research projects at the UMCG.

Vishal G Shelat

Department of General Surgery, Tan Tock Seng Hospital, Singapore 308433, Singapore

vgshelat@rediffmail.com

Gastroenterology Hepatology Oncology Surgery CT scan Liver Scoring

Dr. Vishal G. Shelat is an Associate Professor in the Department of General Surgery, at Tan Tock Seng Hospital, Singapore 308433, Singapore. He is a general surgeon trained in open, laparoscopic, and robotic hepatobiliary and pancreatic surgery, and diagnostic foregut and hindgut endoscopies. He is involved in undergraduate and postgraduate teaching and training. He has also received several hospital, cluster, and medical school-level various teaching awards. He serves as a program director for the PGY1 program and Director of the Surgical Science Training Centre at Tan Tock Seng Hospital. He is involved in various surgical quality and patient safety initiatives. He has conducted local primary care and public seminars/forums to raise cancer awareness and drive patient-centric value-driven safe surgical care. He has a keen interest in healthcare ethics and is an active member of institutional clinical research and ethics committees. He is registered as a medical expert witness and renders medico-legal assistance upon request. He has published >230 papers and >10 book chapters. He has contributed to many international guidelines, delivered >30 oral invited or nominated international lectures, and serves on the editorial board of international journals.

Dr. Weiqing Wan

Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China

weiqingwan111@163.com

Brain Function Brain tumors Glioma Meningioma Pituitary Adenoma Vestibular Schwannona

Dr. Weiqing Wan is a clinical front-line doctor, received his M.D. from Capital Medical University. Adhere to the combination of specific work and learning experience, actively write and apply for projects, presided over and participated in 2 national natural surface projects, and presided over and participated in a number of Sino-US cooperation projects, "863" program.

Weiren Luo

Cancer Research Institute, Department of Pathology, The Second Affiliated Hospital of Southern University of Science and Technology, Shenzhen

Third People's Hospital, National Clinical Research Center for Infectious Diseases, Shenzhen, China

luoweiren@hotmail.com

Experimental Pathology Ecological pathology Medical ecology tree Nasopharyngeal carcinoma ecology

Dr. Weiren Luo is a professor at the Cancer Research Institute within the Department of Pathology at the Second Affiliated Hospital of Southern University of Science and Technology, as well as at the Shenzhen Third People's Hospital, both located in Shenzhen, China. He is also affiliated with the National Clinical Research Center for Infectious Diseases in Shenzhen. Dr. Luo received his Ph.D. from Southern Medical University and conducted research as a Visiting Scholar at the University of California/Lawrence Berkeley National Laboratory, United States.

His primary focus lies in the field of cancer ecology and pathology. He is credited with introducing the concept of human ecological pathology and has developed the cancer ecology tree and the nasopharyngeal carcinoma ecology theory. Notably, during the initial stages of the COVID-19 pandemic, Dr. Luo and his team documented the world's first case of critical COVID-19 biopsy, which revealed the presence of pulmonary fibrosis and microthrombosis.

His research interests span a wide spectrum, including medical and surgical emergencies in nasopharyngeal carcinoma ecology, ecological pathology, medical ecology trees, and experimental pathology.

William C. Cho

Department of Clinical Oncology,Queen Elizabeth Hospital, Hong Kong, China

williamcscho@gmail.com

Cancer biomarkers Cancer diagnosis Cancer treatment predication High-throughput cancer diagnosis

Dr. William Cho is a biomedical scientist at QEH. His main research interests have been focusing on cancer studies utilizing high-throughput technologies to discover biomarkers for cancer diagnosis, treatment prediction, and prognostication. He is a Chartered Scientist granted by the Science Council (UK), a Registered Chinese Medicine Practitioner (HK), a Guest Professor of several universities, and a Fellow Member of several institutes, including the Institute of Biomedical Science (UK), the Hong Kong Institute of Biomedical Science, and the Hong Kong Society for Molecular Diagnostic Sciences. Dr. Cho has published over 500 peer-reviewed papers, including Lancet, Lancet Oncology, Advanced Science, Nature Communications, Clinical Cancer Research, Clinical Chemistry, Annals of Oncology, PNAS, etc., covering cancer biomarkers, proteomics, microRNAs, Chinese medicine, and plenty of books including "MicroRNAs in Cancer Translational Research", "An omics Perspective on Cancer Research", "Supportive Cancer Care with Chinese Medicine", “Drug Repurposing in Cancer Therapy: Approaches and Applications," etc.

Wing Nang Albert Leung

School of Graduate Studies, Lingnan University, Tuen Mun, Hong Kong

albertleung@ln.edu.hk

Experimental medicine Traditional Chinese Medicine

Prof. Wing Nang Albert Leung was the former director of the School of Chinese Medicine at the Chinese University of Hong Kong. He is currently a Professor of Clinical Practice at Lingnan University, Hong Kong. He is the author or co-author of over 150 refereed publications. His major research interests are photodynamic therapy (PDT) using herbal compounds as photosensitizers, the pharmacology of anticancer Chinese medicinal materials, the integration of Chinese and Western medicine in clinical applications, and the application of Chinese medicine in gerontology and elderly care.

Xiaofeng Zhao

Obstetrics and Gynecology Hospital, School of Medicine, Zhejiang University, Hangzhou, China

zhxf@zju.edu.cn

Complex gynecological surgeries performed laparoscopically Complex hysteroscopic procedures Gynecological oncology Pelvic anatomy Pelvic floor dysfunction Surgeries for large uteri

Prof. Xiaofeng Zhao, at the Obstetrics and Gynecology Hospital of Zhejiang University School of Medicine, specializes in pelvic anatomy and complex gynecological surgeries performed laparoscopically. His expertise includes surgeries for large uteri, pelvic floor dysfunction, gynecological oncology, and complex hysteroscopic procedures. He has introduced new anatomical structure models such as the 'double hammock' for pelvic floor support and the 'envelope' membrane anatomy of the lower abdomen and pelvis. Furthermore, he has modified existing procedures based on these anatomical structures.

Xufeng Zhang

Department of Hepatobiliary Surgery and Institute of Advanced Surgical Technology and Engineering, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China

xfzhang125@xjtu.edu.cn

Oncology Surgery Hepatobiliary surgery Transplantation

Dr. Xufeng Zhang is from the First Affiliated Hospital of Xi'an Jiaotong University, the Department of Hepatobiliary Surgery, and the Institute of Advanced Surgical Technology and Engineering. His research topics are oncology, surgery, hepatobiliary surgery, and transplantation.

Yang Shen

shenyang@seu.edu.cn

Comprehensive diagnosis and treatment of gynecological tumors Conventional/single-hole laparoscopic surgery female pelvic floor repair and urinary incontinence treatment

Prof. Shen Yang, at Zhongda Hospital affiliated to Southeast University, specializes in gynecological cancer-related diseases. His expertise includes comprehensive diagnosis and treatment of gynecological tumors, especially conventional/single-port laparoscopic surgery for endometrial cancer, cervical cancer, early ovarian cancer, R0 resection of advanced ovarian cancer, pelvic exenteration for recurrent cervical cancer, and female pelvic floor repair and urinary incontinence treatment. His research interests include the pathogenesis of ovarian/fallopian tube tumors, the reversal of ovarian cancer drug resistance, the relationship between environmental endocrine disruptors and gynecological diseases, the innovation and improvement of gynecological endoscopy technology, the cross-modal navigation control surgical robot for uterine fibroids and polyps, and biomedical synthesis based on computer-aided drug design.

Yong Hai

Department of Orthopedics, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China

yong.hai@ccmu.edu.cn

Biomechanics Bone Degenerative disc disease Disc replacement Scoliosis Spine deformity Spine surgery

Prof. Dr. Yong Hai is head of the Department of Orthopedics at Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China. Prof. Dr. Hai has engaged in basic and clinical research and practice of orthopedic spinal surgery for more than 30 years and is proficient in the diagnosis and treatment of various spinal diseases, especially complex and difficult spinal deformities, with unique and rich diagnostic and therapeutic experience. Prof. Dr. Hai was honored with numerous awards, including the Lancet Award, Beijing Gold Medal Doctor, China Health Communication Ambassador, and the Top Ten Public Welfare Figures of Chinese Physicians. Prof. Dr. Hai published more than 300 professional academic articles (including 150 SCI articles, with a total IF of 500+) and edited or translated nine academic monographs. He has also obtained more than ten national invention and utility model patents.

Yunlei Li

Dept. of Pathology & Clinical Bioinformatics, Ee-1579 Erasmus University Medical Center, Rotterdam, The Netherlands

y.li.1@erasmusmc.nl

Artificial intellegence Clinical bioinformatics Data mining Deep learning Machine learning

Dr. Yunlei Li studied data mining and bioinformatics at Delft University of Technology (TUD) under the supervision of Prof. Marcel Reinders and Prof. Lodewijk Wessels. She conducted her internship at the Netherlands Cancer Institute (NKI) under the supervision of Prof. Laura van ‘t Veer on breast cancer research. In 2004, she obtained her MSc degree with honors (cum laude). She performed her doctoral research at TUD with Prof. Marcel Reinders and Prof. Dick de Ridder and obtained her Ph.D. in 2010 on “Exploiting noisy and incomplete biological data for prediction and knowledge discovery.” Since 2011, Dr. Li has been working at the Erasmus Medical Center (EMC) on multiple basic cancer research projects as well as healthcare-oriented projects covering a wide range of diseases (incl. leukemia, aneurysm, pancreatic cancer, lung cancer, glioblastoma, and melanoma) and bioinformatics applications.

Currently, she is leading the machine learning and artificial intelligence research line in the Department of Pathology and Clinical Bioinformatics at EMC. Her research focuses on designing and applying novel artificial intelligence methods (data mining, machine learning, and deep learning) in translational and clinical research settings to integrate and exploit multi-dimensional patient data (e.g., DNA, RNA, protein, image, clinical) for clinical cancer research and clinical trials in order to gain insight into the diseases, discover biomarkers, improve diagnosis accuracy, and stratify personalized treatments.

Zuoren Yu

Shanghai East Hospital, Jinzhou Medical University, Shanghai 200120, China

Research Center for Translational Medicine, Shanghai East Hospital, Tongji University School of Medicine, Shanghai 200120, China

zuoren.yu@tongji.edu.cn

Cancer metastasis Cancer stem cells Cell cycle regulation Non-coding RNAs

Dr. Zuoren Yu got his Ph.D. degree from the Chinese Academy of Medical Sciences & Peking Union Medical College in 2003, followed by postdoctoral training at the University of Pennsylvania (2004-2006) and Thomas Jefferson University (2006-2009). After a faculty appointment as Assistant Professor of Cancer Biology (2009-2011) at Thomas Jefferson University, Dr. Yu joined Tongji University School of Medicine in 2012, focusing on non-coding RNA regulation on cancer stem cells and cancer metastasis.

Ammar Musawi

Missouri School of Dentistry & Oral Health, A.T. Still University, Kirksville, MO, USA

amusawi@atsu.edu

Dentistry

Ammar Musawi, BDS, MDS (Prosthetic Dentistry), MPH (Dental Emphasis), is the Assistant Dean of the Preclinical Education and Simulation clinic at the Missouri School of Dentistry & Oral Health (MOSDOH). He oversees D1 and D2 students’ preclinical education, MOSDOH’s Kirksville campus facilities, and supervises MOSDOH’s preclinical faculty.

Dr. Musawi received his dental degree from the University of Baghdad (BDS), his Master of Dental Surgery (MDS) in Prosthetic Dentistry from the University of Malaya, and his Master of Public Health (MPH) dental emphasis from ATSU.

Employed with ATSU-MOSDOH since 2014 as the first full-time faculty, his focus in higher education includes developing and implementing new and effective learning methods, assessment and educational research, restorative dentistry research, and other research topics.

Dr. Musawi was honored with the Elsie Gaber Compassion and Integrity Award, the MOSDOH Student Governance Association (SGA) Excellence in Teaching Award, the MOSDOH Teaching Award, a Certificate of Appreciation in recognition of his service during the COVID-19 pandemic, and the American Dental Association (ADAE) Leadership Institute certificate.

Andrew Smith

School of Psychology, Centre for Occupational and Health Psychology, Cardiff University, Cardiff, UK

SmithAP@cardiff.ac.uk

Psychology occupational and health psychology

Prof. Andrew Smith’s research covers the areas of occupational and health psychology, with a major emphasis on well-being.
Specifically, he has conducted extensive research on the non-auditory effects of noise on cognition and health. In addition, he conducts research on stress and fatigue in both the workplace and life in general. His interests in health psychology cover two main themes: health-related behaviors (effects of nutrition, caffeine, and chewing gum on behavior) and minor illnesses (psychosocial risk factors for susceptibility to colds and influenza; effects of upper respiratory tract infections on mood and cognition).

Hideaki Kawabata

Department of Gastroenterology, Kyoto Okamoto Memorial Hospital, Kyoto, Japan

hkawabata@okamoto-hp.or.jp

Endoscopy Gastroenterology

Dr. Hideaki Kawabata is a clinical gastroenterologist and now the Director of Kawabata Medical Clinic, as well as a specialist and councilor in the Japanese Society of Gastroenterology and the Japan Gastroenterological Endoscopy Society and a specialist in the Japanese Society of Internal Medicine and the Japanese Society of Gastrointestinal Cancer Screening.

Lawrence. A. Lavery

Department of Plastic Surgery, The University of Texas Southwestern Medical Center, Dallas, TX, USA

larry.lavery@utsouthwestern.edu

Diabetic foot complications Infections Plastic surgery Wound healing

Lawrence A. Lavery, D.P.M., M.P.H., is a professor in the Department of Plastic Surgery at UT Southwestern Medical Center. He is also the Medical Director of the Diabetic Limb Salvage (DLS) program at Parkland Memorial Hospital and works as part of the DLS team at William P. Clements Jr. University Hospital. Dr. Lavery’s clinic and research interests involve diabetic foot complications, infections, and wound healing.

Dr. Lavery completed his undergraduate studies at Indiana University and then earned his medical degree at the Rosalind Franklin University of Medicine and Science, Dr. William Scholl College of Podiatric Medicine in Chicago. He completed a residency in podiatric medicine and surgery at the University of Texas Health Science Center in San Antonio, where he also earned a Master's degree in Public Health.

He is board-certified by the American Board of Podiatric Surgery and a Fellow of the American College of Foot and Ankle Surgeons and the Royal College of Surgeons (Glasgow).

Prior to joining UT Southwestern in 2010, Dr. Lavery was a professor in the Department of Surgery at the Texas A&M Health Science Center College of Medicine, Scott and White Medical Center in Temple, Texas; the University of Texas Health Science Center in San Antonio; and Loyola University Medical Center in Maywood, Illinois. He has also served as a staff podiatrist at VA hospitals in San Antonio and Maywood, Illinois.

Dr. Lavery’s research group has published over 320 peer-reviewed scientific papers and textbook chapters. They have received research funding from the National Institutes of Health, the Agency for Health Care Policy and Research, the American Diabetes Association, the Veterans Administration, the Qatar National Research Foundation, the American College of Foot and Ankle Surgeons, the American Podiatric Medical Association, and private industry.

Rodrigo Suarez

Department of Urology, Faculty of Medicine and Medical Center, University of Freiburg, Freiburg, Germany

rodrigo.suarez@uniklinik-freiburg.de

Oncology Surgery Urology

Dr. Rodrigo Suarez is from the Department of Urology at the Faculty of Medicine and Medical Center at the University of Freiburg. His research topics are oncology, surgery, and urology.

Roy Hajjar

Department of Surgery, Faculty of Medicine, Université de Montréal, Montréal, Québec, Canada

roy.hajjar@umontreal.ca

Surgery Gastrointestinal surgery

Dr. Roy Hajjar is from the Department of Surgery at the Faculty of Medicine at the Université de Montréal. His research topics are surgery and gastrointestinal surgery.

Samuel Cohen

Department of Anesthesiology, Perioperative and Pain Medicine, Stanford University School of Medicine, Stanford, CA, USA

cohensam@stanford.edu

Anesthesiology Health care systems

Samuel Cohen is a fourth-year medical student at the Stanford School of Medicine. His research interests include examining the intersection of technology and medicine in order to optimize patient care. His most recent work aims to improve patient education materials using artificial intelligence. He has published more than 30 manuscripts in the past three years and looks forward to continuing to advocate for patients via his research throughout his career as an aspiring ophthalmologist.

Stuart Winter

Cancer and Blood Disorders Program, Children's Minnesota, Minneapolis, MN, USA

Stuart.Winter@childrensmn.org

Oncology Pediatrics

Stuart S. Winter, MD, is the Chief Research Officer at Children's Hospitals and Clinics of Minnesota. A Midwesterner since the early 1960s, Stuart grew up near Milwaukee, WI. He graduated from Lawrence University in Appleton, WI (1983) with a BA in biology and attended medical school at the University of Wisconsin-Madison (1988). Stuart completed his pediatric residency at the University of New Mexico (1991) and his sub-specialty fellowship in Hematology/Oncology at Duke University Medical Center (1995). He has been continuously board-certified in Pediatric Hematology-Oncology since 1994. Stuart's areas of interest are molecular oncology, immunotherapy, clinical trials, research ethics, and randomized longitudinal studies that benefit all children.